Mylan Inc. (NYSE:MYL) recently announced its plans to acquire privately held Bioniche Pharma Holdings Ltd for $550 million in cash. The company said it will not assume any of Bioniche’s outstand...
Matrix Laboratories, a subsidiary of Mylan (NYSE:MYL), recently received final approval from the US Food and Drug Administration (FDA) for its generic version (gabapentin) of Pfizer’s (NYSE:PFE) Neu...
Dr Pepper Snapple Group, Inc. (NYSE:DPS) - Shares of the manufacturer of a variety of non-alcoholic beverages rallied 2.45% at the start of the trading session, briefly touching a new 52-week high o...
Recently, Mylan Inc. (NYSE:MYL) received approval from the US Food and Drug Administration (FDA) for its generic version of GlaxoSmithKline’s (NYSE:GSK) Valtrex, a treatment for herpes virus infecti...
Recently, Mylan Inc. (NYSE:MYL) received approval from the US Food and Drug Administration (FDA) for its generic version of GlaxoSmithKline’s (NYSE:GSK) Valtrex, a treatment for herpes virus infecti...
First Quarter Highlights On April 29, Mylan (NYSE:MYL) reported first quarter fiscal 2010 earnings per share (EPS) of 20 cents, down from the year-...
First Quarter Highlights On April 29, Mylan (NYSE:MYL) reported first quarter fiscal 2010 earnings per share (EPS) of 20 cents, down from the year-ago earnings of 23 cents. On an adjusted basis, first...
Mylan (NYSE:MYL) reported first quarter earnings per share of 20 cents, down from the year-ago earnings of 23 cents. On an adjusted basis, first quarter 2010 earnings came in at 36 cents, a couple of ...
Mylan, Inc. (NYSE:MYL) - Shares of the global pharmaceutical company rallied 1.7% at the start of the trading session to secure a new 52-week high of $23.33. The increase in Mylan’s share pri...
Mylan Inc. (NYSE:MYL) received approval from the US Food and Drug Administration (FDA) for the generic version of Braintree Laboratories’ NuLytely, a laxative. The company is eligible to ship th...